Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Nuclear Medicine

Free Subscription Articles published in Appl Radiat Isot Retrieve available abstracts of 64 articles: HTML format

Single Articles

December 2025
1. CARDANI I, Colucci M, Nigron E, Guertin A, et al
   Experimental cross sections and production feasibility of (61)Cu via (59)Co(alpha, 2n) for PET imaging using medium-energy alpha beams.
   Appl Radiat Isot. 2025;229:112377.
   PubMed     Abstract available
   
   
   
2. KEBEDE MT, Dawud JE, Kejela BT, Gannamo MP, et al
   Assessment of radiation protection against knowledge, attitude and practice in nuclear medicine facilities in Addis Ababa, Ethiopia.
   Appl Radiat Isot. 2025;229:112372.
   PubMed     Abstract available
   
   
   
3. ANDRADE EMR, Silva ACM, Ferreira AV, Gontijo RMG, et al
   A prototype of a 3D-printed zoomorphic mouse model for small animal PET scanner calibration.
   Appl Radiat Isot. 2025;229:112362.
   PubMed     Abstract available
   
   
   
4. LUKUMAN B, Murat H, Said MA, Yaakob Y, et al
   Impact of body-mass-index (BMI) on effective dose of whole-body [(18)F] fluorodeoxyglucose PET/CT examinations.
   Appl Radiat Isot. 2025;229:112349.
   PubMed     Abstract available
   
   
   
5. KUMAR P, Mangalore S, Joshi RK, Murthy V, et al
   Production of [(18)F]NAV4694 on an FX2N synthesis module for imaging amyloid plaques.
   Appl Radiat Isot. 2025;226:112216.
   PubMed     Abstract available
   
   
   
6. ROSAR F, Petto S, Ganz S, Burgard C, et al
   Assessment of scintigraphic imaging with Terbium-161: A visual and quantitative analysis.
   Appl Radiat Isot. 2025;226:112171.
   PubMed     Abstract available
   
   
   
7. ARZENTON A, Mariotti E, Scarpa D, Khwairakpam OS, et al
   Laser photo-ionization efficiency of (111)Ag for medical use in the SPES-ISOLPHARM project.
   Appl Radiat Isot. 2025;226:112143.
   PubMed     Abstract available
   
   
   
8. QIU L, Bognar C, Tangadanchu VKR, Moerlein SM, et al
   Automated production of radiotracer [(18)F]FZTA for imaging sphingosine-1-phosphate receptor 1 (S1PR1) in human.
   Appl Radiat Isot. 2025;226:112136.
   PubMed     Abstract available
   
   
   November 2025
9. NASR ZS, Shamsel-Din HA
   Aspergillic acid from Aspergillus flavus: A dual-action discovery for combatting pathogens and pinpointing inflammation via technetium-99m radiolabeling.
   Appl Radiat Isot. 2025;228:112309.
   PubMed     Abstract available
   
   
   
10. KARPUZ M, Aksoyalp ZS
    A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) for therapeutic radiopharmaceuticals.
    Appl Radiat Isot. 2025;228:112306.
    PubMed     Abstract available
    
    
    
11. MULLER M, Staudt M, Garcia-Vazquez R, Hvass L, et al
    Synthesis and in vivo evaluation of a polar [(18)F]BODIPY-Tetrazine as a pretargeted bimodal imaging agent.
    Appl Radiat Isot. 2025;225:112080.
    PubMed     Abstract available
    
    
    
12. SIMPSON SR, Jouad K, Clay AJ, Ghosh A, et al
    Automated radiosynthesis of [(18)F]fluoromannitol on the Sofie Biosciences ELIXYS FLEX/CHEM system.
    Appl Radiat Isot. 2025;225:112076.
    PubMed     Abstract available
    
    
    
13. BARBARO F, Canton L, Uzunov N, De Nardo L, et al
    Hospital-cyclotrons production of high-purity (155)Tb via (155)Gd(p,n).
    Appl Radiat Isot. 2025;225:112026.
    PubMed     Abstract available
    
    
    
14. DE NARDO L, De Dominicis L, Esposito J, Rosato A, et al
    Cellular and multicellular dosimetry of two copper radioisotopes: (67)Cu and (64)Cu.
    Appl Radiat Isot. 2025;225:112041.
    PubMed     Abstract available
    
    
    October 2025
15. ZIMMERMAN BE, Denis-Bacelar AM, Rusnak J
    Needs for radionuclide metrology in the use of alpha-emitters for radionuclide-based therapy: Summary of an International Workshop.
    Appl Radiat Isot. 2025;224:111827.
    PubMed     Abstract available
    
    
    September 2025
16. SHAH SQ, Shirin S
    Head-to-head evaluation of DFO and 3,4,3-LI(1,2-HOPO) chelators through site-specific conjugation of Anti-STEAP1 antibody V6-19-D11 for (89)Zr-immuno-PET imaging.
    Appl Radiat Isot. 2025;226:112168.
    PubMed     Abstract available
    
    
    
17. LI H, Li X, Yang L, Chen L, et al
    Sequential synthesis of [(18)F]FDG and [(68)Ga]Ga-DOTA-TATE on the AllinOne radiosynthesizer: A fully automated dual-radionuclides protocol with single cassette and reagents loading.
    Appl Radiat Isot. 2025;223:111899.
    PubMed     Abstract available
    
    
    August 2025
18. REYES-L S, Molina-Contreras JR, Vega-Carrillo HR
    X-ray and gamma-ray shielding capacity of recycled polyethylene terephthalate (r-PET) added with barite (BaSO(4)) and metal oxide microparticles.
    Appl Radiat Isot. 2025;226:112109.
    PubMed     Abstract available
    
    
    
19. AMADOR DIAZ V, Hall PM, Brown MJ, Vavere AL, et al
    Development and validation of a semi-automated [(13)N]Ammonia preparation system for clinical research.
    Appl Radiat Isot. 2025;222:111861.
    PubMed     Abstract available
    
    
    July 2025
20. GU XB, Yu GB, Liu B, Xiang YX, et al
    A methodological study on measuring the activity of Ac-225 in targeted therapeutic radiopharmaceuticals using CdZnTe.
    Appl Radiat Isot. 2025;225:112066.
    PubMed     Abstract available
    
    
    
21. CHEN J, Xie C, Wu R, Zhang D, et al
    Optimization and automation of the radiosynthesis of PET ligand targeting Abeta for imaging cerebral amyloid angiopathy.
    Appl Radiat Isot. 2025;225:112037.
    PubMed     Abstract available
    
    
    
22. WANG K, Zhu X, Wang Y, Xie J, et al
    Optimization of synthesis conditions of [(68)Ga]Ga-PSMA-D5 and its clinical application in prostate cancer.
    Appl Radiat Isot. 2025;221:111825.
    PubMed     Abstract available
    
    
    
23. EVANGELISTA VLO, Correia PD, Fuzato FQ, Maschio A, et al
    Simulation of the dose received by an occupationally exposed individual in the routine of a nuclear medicine service.
    Appl Radiat Isot. 2025;225:112021.
    PubMed     Abstract available
    
    
    June 2025
24. LI J, Li C, Zheng H, Yaddanapudi K, et al
    Biodistribution studies of (89)Zr-Labeled stem cell-derived exosomes using PET imaging.
    Appl Radiat Isot. 2025;225:112000.
    PubMed     Abstract available
    
    
    
25. MUNIR M, Forentin AM, Febrian MB, Fakih TM, et al
    Radiosynthesis of [(131)I]I-Hesperidin: Optimization, physicochemical profiling, and computational insights for targeted radiopharmaceuticals.
    Appl Radiat Isot. 2025;225:111977.
    PubMed     Abstract available
    
    
    May 2025
26. ANAGNOSTOU I, Michail C, Tseremoglou S, Valais I, et al
    Examining the effect of scatter radiation spread in LaCl(3):Ce and LaBr(3):Ce scintillators under nuclear medicine imaging exposure conditions.
    Appl Radiat Isot. 2025;224:111924.
    PubMed     Abstract available
    
    
    
27. SHEIKHZADEH P, Asami M, Mofrad MS, Abdolmaleki M, et al
    Organ doses, effective dose, and cancer risk estimation from whole-body CT scans in PET-CT imaging.
    Appl Radiat Isot. 2025;224:111892.
    PubMed     Abstract available
    
    
    
28. YANG X, Lv G, Peng Y, Liu Q, et al
    Synthesis and biological evaluation of a (68)Ga-labeled glucose derivative PET probe [(68)Ga]Ga-NOTA-SDG.
    Appl Radiat Isot. 2025;223:111893.
    PubMed     Abstract available
    
    
    April 2025
29. NISSIM S, Aviv O, Brandis M, Weissman L, et al
    Study of positron emission from (36)Cl.
    Appl Radiat Isot. 2025;222:111870.
    PubMed     Abstract available
    
    
    
30. STEINBERG PY, Bietti FT, Gomez N, Casale G, et al
    Densitometric measurement of (18)O content of (18)O-enriched water in relation to the production of (18)F-labelled radiopharmaceuticals.
    Appl Radiat Isot. 2025;222:111848.
    PubMed     Abstract available
    
    
    
31. SAPTIAMA I, Munir M, Qaira IS, Rindiyantono F, et al
    (99m)Tc radiolabeling of palm shell charcoal: A preliminary study for potential lung ventilation scintigraphy agent.
    Appl Radiat Isot. 2025;218:111689.
    PubMed     Abstract available
    
    
    
32. ALHUJAILI SF, Sulieman A, Alrowaili ZA, Alshabibi ASA, et al
    Radiation dose assessment and establishment of diagnostic reference levels for MDP Tc-99m bone scans: A multi-hospital study in Saudi Arabia.
    Appl Radiat Isot. 2025;218:111695.
    PubMed     Abstract available
    
    
    March 2025
33. KIM E, Lee C, Seo Y, Hong D, et al
    Synthesis and evaluation of a (68)Ga-labeled iodinated benzamide derivative as a PET imaging agent for malignant melanoma.
    Appl Radiat Isot. 2025;220:111791.
    PubMed     Abstract available
    
    
    
34. MORTHY P, Musarudin M, Shukor NSA, Said MA, et al
    Accuracy of (177)Lu activity quantification using MCNP5-Modeled SPECT imaging.
    Appl Radiat Isot. 2025;220:111786.
    PubMed     Abstract available
    
    
    
35. KHOSHYARI Z, Jahangir R, Miri-Hakimabad H, Mohammadi N, et al
    Monte Carlo-based estimation of patient absorbed dose in (99m)Tc-DMSA, -MAG3, and -DTPA SPECT imaging using the University of Florida (UF) phantoms.
    Appl Radiat Isot. 2025;220:111772.
    PubMed     Abstract available
    
    
    
36. YU HM, Lin KL, Yang CH, Chan CH, et al
    Development of an (18)F-labeled 5-aroylindole derivative for histone deacetylase 6 imaging in spinocerebellar ataxia.
    Appl Radiat Isot. 2025;217:111650.
    PubMed     Abstract available
    
    
    February 2025
37. A MOHYMEN A, Farag HI, Reda SM, Monem AS, et al
    Impact of reconstruction algorithms at different sphere-to-background ratios on PET quantification: A phantom study.
    Appl Radiat Isot. 2025;220:111761.
    PubMed     Abstract available
    
    
    
38. KOBAYASHI Y, Nakamura S, Takemori M, Nakaichi T, et al
    Comparison of dose distribution with and without reflecting heterogeneous boron distribution using (18)F-BPA positron emission tomography in boron neutron capture therapy.
    Appl Radiat Isot. 2025;219:111720.
    PubMed     Abstract available
    
    
    
39. NABAR SJ, Shet T, Malpani B, Hassan P, et al
    Technetium-99m-labeled stealth liposomes: A new Strategy to Identify metastasis in tumour model.
    Appl Radiat Isot. 2025;218:111709.
    PubMed     Abstract available
    
    
    
40. PATRA S, Ghosh S, Singh K, Chand Sharma S, et al
    Production, radiochemical separation and electrochemical concentration of No-carrier-added (52)Mn: An emerging PET radiometal.
    Appl Radiat Isot. 2025;218:111707.
    PubMed     Abstract available
    
    
    November 2024
41. ALOUFI KM, Gameraddin M, Alhazmi FH, Almazroui IS, et al
    Assessing radiation doses and proposing DRLs for nuclear medicine procedures for pediatric and adult patients in Madinah, Saudi Arabia.
    Appl Radiat Isot. 2024;215:111583.
    PubMed     Abstract available
    
    
    October 2024
42. SONDERGAARD U, Thomas KE, Soborg Pedersen K, Kranz M, et al
    Production of (67)Cu at a biomedical cyclotron via (70)Zn(p,alpha)(67)Cu reaction and its evaluation in a preclinical study using small animal SPECT/CT.
    Appl Radiat Isot. 2024;215:111551.
    PubMed     Abstract available
    
    
    
43. SANTOS JM, Balieiro LM, Santos RS, Matsuda MMN, et al
    Validation of chromatographic methods, TLC and HPLC, to quantify known radiochemical impurities and the radiochemical purity the radiopharmaceutical [(177)Lu]Lu-PSMA I&T.
    Appl Radiat Isot. 2024;215:111557.
    PubMed     Abstract available
    
    
    September 2024
44. SILINDIR-GUNAY M, Ozolmez N
    Adverse reactions to therapeutic radiopharmaceuticals.
    Appl Radiat Isot. 2024;214:111527.
    PubMed     Abstract available
    
    
    
45. KUMAR P, Shanbhag NC, Chaudhari P, Mohanty B, et al
    Radiolabeling and preclinical evaluation of technetium-99m labeled colistin.
    Appl Radiat Isot. 2024;214:111524.
    PubMed     Abstract available
    
    
    August 2024
46. VASIC V, Parodi K, Pinto M
    Evaluating an analytical prediction algorithm of positron emitter distributions in patient data for PET monitoring of carbon ion therapy: A simulation study.
    Appl Radiat Isot. 2024;213:111479.
    PubMed     Abstract available
    
    
    July 2024
47. SPAGNUOLO L, Capogni M, Fazio AA, De Felice P, et al
    National programme for the reliability of ionizing radiation measurements based on inter-laboratory comparisons (ILCs): ILC n degrees 2 'radiopharmaceutical activities'.
    Appl Radiat Isot. 2024;212:111449.
    PubMed     Abstract available
    
    
    
48. WANG M, Arkins CA, Zheng QH, Glick-Wilson B, et al
    Development and validation of a HPLC method for the determination of chemical and radiochemical purity of O-(2-[(18)F]fluoroethyl-l-tyrosine ([(18)F]FET)), a PET radiotracer for the imaging of brain tumor.
    Appl Radiat Isot. 2024;212:111444.
    PubMed     Abstract available
    
    
    June 2024
49. KANG KJ, Kim YG, Oh SJ, Won J, et al
    Determination of optimal injection dose in a small animal-dedicated positron emission tomography for non-human primate neurological studies.
    Appl Radiat Isot. 2024;211:111404.
    PubMed     Abstract available
    
    
    
50. HARPER R, Morim DR, Mehta D, Rosecker V, et al
    Optimised production of technetium-94m for PET imaging by proton-irradiation of phosphomolybdic acid in cyclotron liquid target.
    Appl Radiat Isot. 2024;210:111381.
    PubMed     Abstract available
    
    
    May 2024
51. ZOLGHADRI S, Mohammadpour-Ghazi F, Yousefnia H
    Preclinical studies and absorbed dose estimation of [(89)Zr]Zr-DFO-Bevacizumab for PET imaging of VEGF-expressing tumors.
    Appl Radiat Isot. 2024;210:111379.
    PubMed     Abstract available
    
    
    
52. YAZDANI E, Asadi M, Geramifar P, Karamzade-Ziarati N, et al
    A step toward simplified dosimetry of radiopharmaceutical therapy via SPECT frame duration reduction.
    Appl Radiat Isot. 2024;210:111378.
    PubMed     Abstract available
    
    
    
53. VAVERE AL, Ghosh A, Amador Diaz V, Clay AJ, et al
    Automated radiosynthesis of [(18)F]DPA-714 on a commercially available IBA Synthera(R).
    Appl Radiat Isot. 2024;207:111257.
    PubMed     Abstract available
    
    
    April 2024
54. VIERA MA, Metidieri Cruz Malthez AL
    Radioprotection in the production of (18)F-FDG at Brazilian cyclotron facilities: A comparative study based on dosimetry.
    Appl Radiat Isot. 2024;206:111189.
    PubMed     Abstract available
    
    
    
55. DELLEPIANE G, Casolaro P, Gottstein A, Mateu I, et al
    (44)Sc production from enriched (47)TiO(2) targets with a medical cyclotron.
    Appl Radiat Isot. 2024;206:111220.
    PubMed     Abstract available
    
    
    March 2024
56. RANJBAR H, Bagheri R, Miremad SM
    Evaluation of (188)Re- IBA as a novel radiopharmaceutical for bone marrow ablation.
    Appl Radiat Isot. 2024;208:111300.
    PubMed     Abstract available
    
    
    February 2024
57. PENG L, Yang T, Zhang D, Wu R, et al
    Optimization and automation of the radiosynthesis of [(18)F]Lu-LuFL as a clinically useful PET ligand targeting FAP for tumor imaging.
    Appl Radiat Isot. 2024;207:111247.
    PubMed     Abstract available
    
    
    December 2023
58. ASHHAR Z, Ahmad Fadzil MF, Md Safee Z, Aziz F, et al
    Performance evaluation of Gallium-68 radiopharmaceuticals production using liquid target PETtrace 800 cyclotron.
    Appl Radiat Isot. 2023;205:111161.
    PubMed     Abstract available
    
    
    
59. DEGUELDRE C, Findlay J, Cheneler D, Sardar S, et al
    Short life fission products extracted from molten salt reactor fuel for radiopharmaceutical applications.
    Appl Radiat Isot. 2023;205:111146.
    PubMed     Abstract available
    
    
    
60. MYBURGH PJ, Moore MD, Pathirannahel BL, Grace LR, et al
    Fully automated production of [(11)C]PiB for clinical use on Trasis-AllinOne synthesizer module.
    Appl Radiat Isot. 2023;202:111040.
    PubMed     Abstract available
    
    
    November 2023
61. KOVAN B
    The effects of kilovoltage (kV) and milliampere seconds (mAs) values for SPECT attenuation correction: An anthropomorphic phantom study.
    Appl Radiat Isot. 2023;204:111118.
    PubMed     Abstract available
    
    
    
62. OZOLMEZ N, Silindir-Gunay M, Volkan-Salanci B
    An overview: Radiotracers and nano-radiopharmaceuticals for diagnosis of Parkinson's disease.
    Appl Radiat Isot. 2023;203:111110.
    PubMed     Abstract available
    
    
    October 2023
63. SALAH H, Sulieman A, Alkhorayef M, Alkhybari E, et al
    Evaluation of personal dose equivalents during positron emission tomography and computed tomography imaging.
    Appl Radiat Isot. 2023;203:111078.
    PubMed     Abstract available
    
    
    
64. DE LA FUENTE-MENDOZA JE, Azorin-Vega EP, Mendoza-Nava HJ, Rodriguez-Martinez G, et al
    Estimation of the relative biological effectiveness (RBE) of the Lu-DOTA-iPSMA177
    Appl Radiat Isot. 2023;202:111065.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.